Female Lynch syndrome carriers should be counseled extensively, discussing the limited evidence for current forms of gynaecological surveillance and personal factors such as their endometrial carcinoma risk (based on MMR gene involved), age, and expectations of surveillance and preventative surgery. The gene discussed is MRC1; the disease is endometrial carcinoma.